MEUSW News and Press, 23andMe Holding Co. Warrant

2024-05-23 19:44:09 ET 23andMe Holding Co. (ME) Q4 2024 Earnings Conference Call May 24, 2024 4:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Joe Selsavage - Chief Financial Officer and Chief Accounting Officer Anne Wojcicki - C...

2024-02-07 21:22:04 ET 23andMe Holding Co. (ME) Q3 2024 Earnings Conference Call February 07, 2024 04:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Joseph Selsavage - Interi...

2023-11-08 20:18:05 ET 23andMe Holding Co. (ME) Q2 2024 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Ian Cooney - Senior Director, IR Anne Wojcicki - Chief Executive Officer and Co-Founder Joseph Selsavage - Interim Chief Financial an...

2023-08-08 19:52:10 ET 23andMe Holding Co. (ME) Q1 2024 Results Conference Call August 08, 2023 04:30 PM ET Company Participants Katie Watson - Vice President of Communications Anne Wojcicki - Chief Executive Officer and Co-Founder Joe Selsavage - Interim Chief F...

2023-05-25 21:30:23 ET 23andMe Holding Co. (ME) Q4 2023 Results Conference Call May 25, 2023 04:30 PM ET Company Participants Maeve Conneighton - Investor Relations at Argo Partners Anne Wojcicki - Chief Executive Officer & Co-Founder Joe Selsavage - Interim ...

2023-04-03 08:55:13 ET Summary In December of 2022 I introduced a number of stocks which I was adding to my "Tax Loss Selling Basket". In this article I summarize the logic and criteria for the basket. I then tally up the results including calculating overall returns and looki...

2023-03-29 13:26:31 ET Summary 23andMe is known around the world for its ancestry DNA genetic testing service. The company's pivot into therapeutics seems attractive. But the company saw revenue decrease from $441 million in 2019 to $272 in 2022. What's the value of having...

2023-03-29 07:56:11 ET Summary GeneDx Holdings Corp. has had a dreadful performance as a stock. GeneDx's number of shares outstanding have absolutely exploded. GeneDx has a negative gross margin and is significantly burning cash. While its business model has merit, you nee...

23andMe Holding Co. (ME) Q3 2022 Earnings Conference Call Feb 08, 2023, 04:30 PM ET Company Participants Wade Walke - VP, Investor Relations Anne Wojcicki - CEO & Co-Founder Joe Selsavage - Interim CFO & Accounting Officer Kenneth Hillan - Chief Therapeutic...

Summary NVTA Q4 cash balance remained flat year-over-year at $555M, with 2022 revenue declining by $4M to $122M. Shares appreciated 25% after last week's Q4 purview on optimism over management's ability to trim operating costs, which would provide NVTA with sufficient runway to execute ...